74V-29652-80299 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-20
Dose 1 — Pfizer-BioNTech
2022-01-08
Dose 2 — Pfizer-BioNTech
2022-03-07
Registered in v-safe
2022-04-09
Survey response — 3 months, dose 2
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Ms aggravated since second vaccination. In horrible flare wish I never got it. Highly do NOT recommend for any autoimmune patients

MedDRA releases: 2024-11 · check-in free text available
2022-04-09
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-13
Call 2 — Could Not Reach Participant
2022-04-14
Call 3 — Could Not Reach Participant
2022-07-09
Survey response — 6 months, dose 2
MedDRA: Dysphagia, Fatigue, Multiple sclerosis, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Trouble swallowing fatigue ms symptoms all worse

MedDRA releases: 2024-11 · check-in free text available
2022-07-09
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-12
Call X — Requested Callback
2022-07-12
Call 2 — Requested Callback
2022-07-18
Call 3 — Left Voicemail
2022-07-18
Callback requested for
10:00AM ET
2023-01-08
Survey response — 12 months, dose 2
MedDRA: Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-01-08
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2023-01-10
Call 1 — Left Voicemail
2023-01-10
Call 1 — Left Voicemail
2023-01-10
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-20	Pfizer-BioNTech	No
2	2022-01-08	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-04-09	Unsuccessful
2022-07-09	Unsuccessful
2023-01-08	Unsuccessful

Free text

Release 11 — 3 months, dose 2

2022-04-09

Symptoms: Ms aggravated since second vaccination. In horrible flare wish I never got it. Highly do NOT recommend for any autoimmune patients

Release 12 — 6 months, dose 2

2022-07-09

Symptoms: Trouble swallowing fatigue ms symptoms all worse

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dysphagia	·	·	✓
SD	Fatigue	·	·	✓
SD	Multiple sclerosis	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release